Zepbound is approved for weight loss
But now that progress is at risk
Last week, a federal judge ruled that compounders could not continue making tirzepatide injections while a lawsuit filed by Outsourcing Facilities Association (OFA) against the U.S
But as Professor Stefan Trapp, an expert in autonomic neuroscience and metabolic disease at University College London, explains, GLP-1s role in appetite is far more complex - with two distinct sources (gut and brain) acting through very different mechanisms
Lifestyle factors, adherence to dosing, and your bodys unique chemistry all play a role in your weight loss journey Side Effects & Safety Both medications have similar side effects, including: Nausea, vomiting, and diarrhea Decreased appetite Potential blood sugar changes However, some patients report that Tirzepatide has a higher likelihood of gastrointestinal side effects in the early weeks of treatment
The semaglutide group lost an average of 14.9 percent body weight compared to 2.4 percent in the diet-only group